Overview

This guide provides a systematic medico-legal argument for the integration of high-dose baclofen pharmacotherapy into the adjudication of alcohol-related proceedings in criminal and family law. It posits that prevailing legal doctrine rests upon an antiquated behavioural model of alcohol use disorder, leading to outcomes that conflate symptomatology with culpability. The work bridges contemporary neuropharmacological research-specifically the anxiety-dysphoria model of addiction and the mechanism of baclofen as a craving-suppression agent-with core legal concepts of mens rea, capacity, and the 'best interests of the child'. It argues that successful pharmacological treatment of the underlying neurological dysfunction necessitates a doctrinal shift: the legal focus must evolve from punishing past behaviour to recognizing remedied present reality. Structured as a core treatise with an updating service, the book is designed for practitioners and scholars. Part I establishes the enduring legal, medical, and ethical principles. Part II, the January 2026 Update, provides current information on medical regulation, case law, and procedure. The argument presented is derived from the author's earlier work (Medico-Legal Aspects of High-Dose Baclofen, 2019) and has been applied in reported legal proceedings. This guide is intended for criminal defense and family law attorneys, judges, legal academics, and medical professionals seeking a coherent framework at the intersection of neuroscience and justice.

Full Product Details

9798243353212

Table of Contents

Reviews

Author Information

Tab Content 6

Countries Available